ADVERTISEMENT
Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizPozen shares sink on news of Hatch-Waxman challenge
By Lawrence B. Ebert, Esq.
ADVERTISEMENTS
In the Hatch-Waxman area, Pozen, Inc. announced Par Pharmaceutical Inc. has filed an application with the Food and Drug Administration [FDA] to make a generic version of Treximet, a migraine treatment Pozen developed with GlaxoSmithKline PLC, and shares of Pozen shed nearly 28 percent of their value on 17 Oct. 08Full post as published by IPBiz on October 18, 2008 (boomark / email).
Lawsuits and Settlements
AireSurf Networks Holdings Inc.
$23,147 debt settlement made by issuance of 115,735 common shares.
Murphy City, TX
$255,000 settlement in controversial pedophile news program case.
Newspaper Employees
Chinese Daily News must pay $5.19 million class action settlement for failing to pay overtime.
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

A Welfare Analysis of Prohibitions on Reverse Payments in Pharmaceutical Patent Disputes
Hatch-Waxman Safe Harbor Doesnt Apply to Device Not Subject to FDA Approval
Covenant not to sue removes jurisdiction despite lingering Hatch-Waxman exclusivity issues








